September 29, 2021 | New Jersey Law Journal
Compulsory Licensing and March-in Rights in COVID-19 Vaccine ProductionMarch-in rights are a measure intended to protect against nonuse or unreasonable use of federally funded inventions. The federal agency under whose funding agreement the subject invention was made has the right to require the granting of a license to a responsible applicant.
By Keith McWha
9 minute read
September 12, 2014 | New Jersey Law Journal
U.S. Supreme Court Sheds New Light on Patent Licensing RelationshipsHow recent U.S. Supreme Court opinions will impact current and future relationships between patent licensors and patent licensees.
By Keith McWha, Matthew Sklar and Elina Slavin
8 minute read
October 25, 2013 | Connecticut Law Tribune
IP Law: Rulings Focus On Genetic Testing And Modified SoybeansThis year, the U.S. Supreme Court issued two significant opinions that will impact patent protection in the life sciences arena for many years to come. Arguably, the court seesawed by strengthening patent protection in one opinion while weakening patent protection in the other by declaring that certain discoveries cannot be patented.
By KEITH McWHA and MATTHEW SKLAR
7 minute read
September 26, 2013 | New Jersey Law Journal
U.S. Supreme Court Addresses Patent Protection in the Life Sciences ArenaShould scientific innovation be rewarded? Our highest court seems to think so.
By Keith McWha and Matthew Sklar
7 minute read